Red Light Holland Archives - Green Market Report

StaffAugust 30, 2021
psychedelic.jpg?fit=960%2C640&ssl=1

3min7130

Psychedelic companies Red Light Holland Corp. (CSE: TRIP) (OTC Pink: TRUFF) and Creso Pharma Limited (ASX: CPH) (OTCQB: COPHF)  have mutually agreed to terminate the previously announced plan to merge. The two companies had announced in June they would combine, but now cite various impacts from the COVID-19 pandemic, including significant travel restrictions, where they decided that the merger would no longer be in the best interests of their respective shareholders.

“While we determined that a merger was no longer in the best interests of the two companies, we look forward to continuing to work closely with Adam Blumenthal and the rest of the Creso Pharma team as Red Light Holland has agreed to white-label Creso Pharma’s products and distribute them across our SR-Wholesale sales channels,” said Todd Shapiro, CEO and Director of Red Light Holland. “We are also continuing our search for other M&A opportunities as we are confident that our large cash balance puts us in a position of strength as potential progressive regulatory changes in the North American psychedelic and recreational cannabis sectors open up.” Red Light Holland did not that Bruce Linton, the founder and former chief executive officer of Canopy Growth Corporation, will remain as a Chairman of Red Light Holland’s Advisory Board.

As the two companies have significant operations in multiple countries across the globe, the two said that it became increasingly apparent that integration difficulties would limit the anticipated synergies from the proposed merger. The two companies were going to create a new business named The HighBrid Lab. The transaction was to be a reverse takeover of Red Light Holland by Creso Pharma giving Red Light shareholders a 29% premium for their shares. Creso shareholders would’ve owned 57% of the new company.  The new company was expected to have a cash balance of approximately C$45 million.

“We respect Todd Shapiro and the entire team at Red Light Holland. Unfortunately, the geographic span of our respective businesses made a merger at this time impractical,” added Creso Pharma’s Non-Executive Chairman, Adam Blumenthal. “We look forward to working with the Red Light Holland team through our new supply arrangement.”

 


Debra BorchardtJune 16, 2021
shutterstock_1517440529-scaled.jpg?fit=960%2C640&ssl=1

6min16580

Cannabis company Creso Pharma Limited  (ASX: CPH)  (OTCQB: COPHF) is merging with psychedelic treatment company Red Light Holland Corp. (CSE: TRIP) (OTC Pink: TRUFF) to create The HighBrid Lab. The transaction is a reverse takeover of Red Light Holland by Creso Pharma giving Red Light shareholders a 29% premium for their shares. Creso shareholders will own 57% of the new company.

The combined company will use the symbol TRIP. The new company is expected to have a cash balance of approximately C$45 million (A$48 million), providing considerable financial flexibility to progress its growth strategy.

Red Light Holland’s current Chief Executive Officer, Todd Shapiro, will lead HighBrid as CEO and Director.

“The company understands the sensitive complexities of the ingredients we deal with, while ensuring we continue to make a bold yet careful push to provide and increase access for immediate revenue generation and brand expansion. Our core principle is to compliantly lead with edgy consumer packaged goods focused on positive outcomes, while balancing a responsible, regulated, and educational use approach through technology and innovation,” said Todd Shapiro CEO and Director of Red Light Holland. “Merging with Creso Pharma, who also has significant cash on hand, and formulating The HighBrid Lab, with Bruce Linton as Chair of the Board, means we can expand our premium product offerings globally in the high growth CBD, THC and psychedelic sectors. Together we are bullish on developing world-class products with naturally occurring ingredients in clever and innovative ways for both humans and pets, which completely aligns with Creso Pharma’s R&D and sales approach. The HighBrid Lab ramps up our objectives for near and long-term growth targets, while potentially being a part of positive change. The HighBrid Lab is a perfect name combining psychedelics and cannabis coupled with recreational use, science, and technology. This is a monumental day for all of our shareholders and now their pets!”

Former Canopy Growth founder Bruce Linton is expected to join as Non-Executive Chairman of The HighBrid Lab’s board of directors. The board of directors will consist of seven members, three of which, including Mr. Shapiro, will be current directors of Red Light Holland, and three of which, will be directors or nominees of Creso Pharma.Mr. Bruce Linton is expected to be the seventh member, as non-executive Chairman. Mr. William Lay, previously Associate Director, M&A at Canopy Growth appointed Executive Vice President and Chief Strategy Officer to assist in growth trajectory.

“Having worked with both the Creso Pharma and Red Light Holland teams closely in the past, I am really excited by the potential this combination brings. As a merged company, The HighBrid Lab has access to four of the highest growth industry segments around, and the team, board and advisory group to make real progress within these verticals. I’m really looking forward to rolling up my sleeves and helping The HighBrid Lab get to work!” said Bruce Linton, who is expected to join the Combined Company’s board as non-executive Chairman.

Growth Objectives

HighBrid said its growth objectives include expanding market and brand leadership in recreational psilocybin. Applied science and innovation supporting long-term opportunities in psychedelics with both naturally occurring and pharmaceutical grade drug discovery aiming for advanced and approved product offerings through controlled lab environments via the pending acquisitions of Halucenex and Mera Life Sciences. Creso Pharma has conditionally agreed to acquire Canada-based psychedelics life sciences company, Halucenex, which has submitted an application for a Dealer’s License under both the Narcotics Control Regulations and Part J of the Food and Drugs Regulations. Red Light Holland recently extended its LOI with Mera Life Sciences and continues discussions regarding a previously announced potential investment in St. Vincent and the Grenadines, which is expected to be a part of the Combined Company’s applied science platform.

Despite the move towards psychedelics, the company said it will continue scaling its recreational cannabis offering in North America by focusing on increasing market share in Canada and taking advantage of its CSE listing to advance the introduction of products into the US.

In addition to separate paths for cannabis and mushrooms, the company said it plans on introducing recreational product offerings under existing Red Light Holland brands with applied science including combined CBD and mushroom products and ready to drink products with mushrooms, CBD and THC, while focusing on adding adjacent iMicrodose product lines with ingredients including CBD, THC and functional mushrooms, as and where permitted to do so. Already the market is seeing the introduction of CBD combinations with various legal mushroom products like Lions Mane, Reishi and Cordyceps.

 


StaffMarch 19, 2021
mushroom5.jpg?fit=960%2C523&ssl=1

3min18280

Ontario-based mushroom company Red Light Holland Corp. (OTC: TRUFF) announced that its wholly-owned subsidiary, RLH Netherlands B.V.  has completed the acquisition of SR Wholesale B.V., one of the Netherlands’ premiere distributors for quality psychedelic truffles. The company said in a statement that in 2020, SR Wholesale generated over $2.44 Million in revenues, and over $822,000 in gross profit, with approximately $400,000 of cash and working capital currently on hand.

The acquisition will give Red Light Holland access to many product offerings within the psychedelic sector including obtaining sole-ownership of the established Mister Maka Brand which produces Magic Truffles. It will also give Red Light Holland the instant opportunity to white-label to help with brand growth, exposure, and expansion.

“The acquisition of SR Wholesale marks the latest step in the company’s growth and expansion strategy, as we continue to move forward with a positive business outlook focused on achieving revenue growth, profitability, and value creation for our shareholders. We expect this transaction to serve as a launchpad for Red Light Holland to broaden operations, create new homes for our iMicrodose packs and build brand exposure into multiple European markets.” said Todd Shapiro, the Chief Executive Officer and Director of the Company. “We are quite thrilled, after months of tough negotiations and careful due diligence, to move forward as the largest legal psychedelic distribution publicly traded company in the world. As well, we are truly so pleased to work closely with Mr. Shai Ramsahai, who is one of the brightest, most determined and likeable entrepreneurs I’ve ever come across.”

“This is an exciting time for both SR Wholesale and Red Light Holland. After years of hard work we have established an incredible and profitable Distribution company with a huge network across the Netherlands and Europe. I believe that moving forward with Hans Derix (Red Light Holland’s President) and Todd Shapiro coupled with our extremely knowledgeable, loyal and committed team, that together we can grow our wholesale business to new heights,” said Shai Ramsahai, Founder of SR-Wholesale.

SR Wholesale also distributes popular CBD products, cannabis seeds, smart shop items, and headshop products, among others. SR Wholesale has established a distribution network of over 400 companies that sell their products across Europe, including working with sub-distributors that provide products to over 1,000 shops in countries like the Netherlands, Germany, Spain, Czech, Greece, UK, France, and Portugal.


Don't Miss This Week's Groundbreaking News

Join the thousands of subscribers who stay informed with GMR's exclusive news briefs delivered directly to your inbox every Friday afternoon.

We respect your privacy. See our privacy policy.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 2 days

RT : Air fives for our Head of Operations, Eric Lopez! Eric leads the execution of our company’s growth strategy across mar…

Back to Top